Document is current

Article History

Received: 3 September 2018

Accepted: 22 February 2019

First Online: 22 April 2019

Authors’ information

: PPH received his MD degree in 2009 and his PhD degree in 2013 from Shandong University, Jinan, Shandong, China. Currently, Dr. Hao is an attending physician at the Department of Cardiology, Shandong University Qilu Hospital, Jinan. His research interests involve the mechanisms and therapeutic targets of heart failure, atherosclerosis and hyperlipidemia.ZWZ, MD, PhD., Division of Endocrinology, Department of Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University.ZWZ completed her M.D. and Ph.D. degree at Shandong University. ZWZ’s research focuses on molecular mechanisms of metabolic related diseases, including atherosclerosis, hyperlipidemia and diabetic vasculopathy. Dr. Zhang has authored a number of papers in scientific journals and obtained a series of national research grants. ZWZ’s research for hyperlipidemia was published at the European annual conference on diabetes (EASD), the abstract was awarded the 50th EASD Annual Meeting Travel Grant and was included in Diabetologia.HLY, MM. candidate, Graduate School of Medicine, University of Jinan-Shandong Academy of Medical Sciences.HLY’ thesis work is to investigate the relationship between gene polymorphism and risk of diabetes.

: Not applicable.

: All the authors have agreed to publish this article.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.